Hywel Dda University Health Board (UHB) has published its Research and Innovation Strategy, which will help deliver clinical services to the people of Carmarthenshire, Ceredigion and Pembrokeshire.
The strategy, which is part of Hywel Dda UHB’s long-term health and care strategy, A healthier Mid and West Wales: Our Future Generations Living Well, seeks to improve the profile, quality and quantity of research and innovation activity within Hywel Dda UHB.
Additionally, while the COVID-19 pandemic has had devastating impact on communities across mid and west Wales, it demonstrated the vital link between research, innovation, and decision making at every level of the health care system. This includes the immediate importance of translating research and innovation into health benefits.
The Research and Innovation Strategy will focus on setting the direction and committing to the delivery of practical steps to move the health board’s research, development, and innovation agenda forward. This will be achieved through four strategic goals:
Leighton Phillips, Director for Research, Innovation and University Partnerships for Hywel Dda UHB, said: “Our vision is to produce and collaborate in high quality health and care research and innovation, to improve services and health outcomes for our public, patients and staff. This strategy details how we aim to improve our research and innovation capabilities, which will have a direct benefit on the communities we serve in the three counties.
“The COVID-19 pandemic has shown just how critical research and innovation is to deal with the worst public health crisis of our time. Excellent research and innovation contribute to improved health outcomes, because it embeds a culture of the highest standards of health and care delivery, underpinned by evidence and by attracting high quality employees.
“Implementing this strategy will be done in collaboration with a wide variety of partners, from our existing funders, local authorities and Welsh Government, to private sector organisations and industry, and the health board’s clinical and managerial teams.”
If you wish to review the strategy or discuss it further with the research and innovation team, please email firstname.lastname@example.org.